SCHEMBL6868705

SCHEMBL6868705

CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)Nc3ccc(F)cc3F)CC2)nc2c1CCCC2

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
POLB P06746 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.48
MCHR1 Q99705 11/20 0.46
ADRA2A P08913 5/20 0.46
ADRA1A P35348 3/20 0.46
HRH1 P35367 2/20 0.46
HTR2B P41595 2/20 0.46
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTR1A P08908 1/20 0.43
NPY5R Q15761 1/20 0.43
PAK1 Q13153 1/20 0.42
DRD2 P14416 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1B P35368 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6868709 1.00 NPC1 (0.53) NPC1RAB9APOLBL3MBTL1MCHR1
SCHEMBL6874965 0.93 MCHR1 (0.47) NPC1RAB9APOLBL3MBTL1MCHR1
SCHEMBL6874958 0.93 MCHR1 (0.47) NPC1RAB9APOLBL3MBTL1MCHR1
SCHEMBL6875347 0.91 MCHR1 (0.43) NPC1RAB9APOLBL3MBTL1MCHR1
SCHEMBL6875350 0.91 MCHR1 (0.43) NPC1RAB9APOLBL3MBTL1MCHR1
SCHEMBL6878918 0.91 MCHR1 (0.48) NPC1RAB9APOLBMCHR1ADRA2A
SCHEMBL6878910 0.91 MCHR1 (0.48) NPC1RAB9APOLBMCHR1ADRA2A
SCHEMBL6866729 0.89 MCHR1 (0.42) NPC1RAB9APOLBMCHR1ADRA2A
SCHEMBL6866736 0.89 MCHR1 (0.42) NPC1RAB9APOLBMCHR1ADRA2A
SCHEMBL6869037 0.89 KMT2A (0.52) NPC1RAB9APOLBMCHR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed